Reference is made to Navamedic ASA’s (the “Company“) stock exchange announcement dated 19 June 2019 regarding the proposed demerger of the Company.

The demerger is subject to the approval by the Company’s General Meeting and the board of directors has summoned to an Extraordinary General Meeting to be held at 15:00 hours (CET) on 5 August 2019 at the Company’s offices in Henrik Ibsens gate 90, 3rdfloor (House of Business),0255 Oslo. Notice of the meeting has been sent to all shareholders with known address. Attached hereto is the notice of the Extraordinary General Meeting and the demerger plan. The demerger plan and other demerger documents can also be found at the Company’s webpage www.navamedic.com.

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 860
E-mail: kathrine@navamedic.com

Toril Ås, CFO, Navamedic
Mobile: +47 957 01 071
E-mail: toril.as@navamedic.com